Saraiva Roberto M, Duarte Dario M, Duarte Monica P C, Martins Adriana F, Poltronieri Alexandre V G, Ferreira Maria E, Silva Marcia C, Hohleuwerger Rosangela, Ellis Alberto, Rachid Mauricio B, Monteiro Carla F C, Kaiser Sérgio E
Total Care, Rio de Janeiro, Brazil.
Echocardiography. 2005 Aug;22(7):561-70. doi: 10.1111/j.1540-8175.2005.40051.x.
Early recognition of heart disease in diabetics is a highly desirable goal, and diastolic dysfunction, one of its earliest manifestations, can be readily assessed by tissue Doppler imaging. We tested in normotensive diabetics without signs of coronary artery disease whether tissue Doppler imaging would improve the diagnosis of diastolic dysfunction beyond classical criteria and identify patients already presenting impaired cardiac performance.
We studied 79 patients (56 males, 55 type-2 diabetes mellitus) who underwent Doppler echocardiography, and exercise testing. Diastolic dysfunction was diagnosed either based on European Study Group on Diastolic Heart Failure guidelines or by tissue Doppler imaging provided that both of the following criteria were met: Em/Am ratio <1; and Em < 8.5 cm/sec.
Tissue Doppler imaging identified diastolic dysfunction in 26.6% of diabetics, while classical criteria did so in 40.5% of the cases. The group identified by classical criteria did not differ significantly from patients without diastolic dysfunction, while in the group identified by Tissue Doppler imaging, significant differences were highlighted, including worse exercise tolerance and higher left ventricular mass index. Moreover, in multiple regression analysis, Em myocardial velocity and body mass index were the only variables independently related to exercise tolerance.
Differently from classical criteria based on pulsed Doppler, Tissue Doppler imaging identifies a group of asymptomatic normotensive diabetics with diastolic dysfunction and reduced exercise tolerance. Confirmation of the prognostic importance of our findings could justify the use of Tissue Doppler imaging for diastolic function assessment in diabetics with otherwise healthy hearts.
早期识别糖尿病患者的心脏病是一个非常理想的目标,舒张功能障碍作为其最早的表现之一,可通过组织多普勒成像轻松评估。我们在无冠状动脉疾病迹象的血压正常的糖尿病患者中进行测试,以确定组织多普勒成像是否能在经典标准之外改善舒张功能障碍的诊断,并识别出已经存在心脏功能受损的患者。
我们研究了79例患者(56例男性,55例2型糖尿病),这些患者接受了多普勒超声心动图检查和运动测试。舒张功能障碍的诊断要么基于欧洲舒张性心力衰竭研究组的指南,要么通过组织多普勒成像,前提是满足以下两个标准:Em/Am比值<1;且Em<8.5厘米/秒。
组织多普勒成像在26.6%的糖尿病患者中识别出舒张功能障碍,而经典标准在40.5%的病例中识别出舒张功能障碍。经典标准识别出的组与无舒张功能障碍的患者无显著差异,而在组织多普勒成像识别出的组中,突出显示了显著差异,包括运动耐量更差和左心室质量指数更高。此外,在多元回归分析中,Em心肌速度和体重指数是与运动耐量独立相关的唯一变量。
与基于脉冲多普勒的经典标准不同,组织多普勒成像识别出一组无症状的血压正常的糖尿病患者,他们存在舒张功能障碍且运动耐量降低。证实我们研究结果的预后重要性可能证明在心脏其他方面健康的糖尿病患者中使用组织多普勒成像评估舒张功能是合理的。